Abcam Share Price, News & Analysis (LON:ABC) GBX 1,226 +123.00 (+11.15%) (As of 12/13/2022) Add Compare Share Share Today's Range 1,115▼ 1,25950-Day Range 1,226▼ 1,22652-Week Range 1,013.57▼ 1,760Volume6.37 million shsAverage Volume392,791 shsMarket Capitalization£2.81 billionP/E Ratio20,433.33Dividend Yield0.91%Price TargetN/A Stock AnalysisStock AnalysisHeadlinesInsider TradesStock AnalysisHeadlinesInsider Trades About Abcam Stock (LON:ABC)Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.Read More ABC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ABC Stock News HeadlinesNovember 29, 2023 | americanbankingnews.comAbcam (LON:ABC) Stock Price Crosses Below 200-Day Moving Average of $1,226.00November 17, 2023 | msn.comAbcam gains after securing all approves for Danaher sale, set to close Dec. 6December 2, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 9, 2023 | finance.yahoo.comHere’s Why Baron Discovery Fund Sold Abcam plc (ABCM)November 1, 2023 | msn.comJonathan Milner withdraws campaign to vote against Danaher’s bid for AbcamNovember 1, 2023 | markets.businessinsider.comStatement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaignOctober 26, 2023 | msn.comAbcam holder Starboard Value said to sell stake - reportOctober 24, 2023 | cnbc.comWe're buying more of this life sciences stock after an earnings-driven declineDecember 2, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.October 19, 2023 | uk.investing.comThursday newspaper round-up: Inflation target, Amazon, AbcamOctober 18, 2023 | thetimes.co.ukAbcam chiefs set for $29m payoutOctober 12, 2023 | msn.comAbcam CEO ‘feels great’ as shareholder meeting date is fixed for Danaher dealOctober 5, 2023 | finance.yahoo.comAbcam Files and Mails Scheme Circular Seeking Approval of Acquisition of Abcam by Danaher for $24.00 per ShareSeptember 28, 2023 | thetimes.co.ukFounder Jonathan Milner renews battle to prevent Abcam takeoverSeptember 20, 2023 | msn.comAbcam founder considering options to regain company amid takeover - reportSeptember 13, 2023 | finance.yahoo.comNanoString Launches the Most Comprehensive Spatial Proteomics Panel Ever OfferedSeptember 4, 2023 | thetimes.co.ukAbcam sale plan faces opposition from its founder Jonathan MilnerSeptember 1, 2023 | msn.comAbcam ticks higher as founder Milner says Danaher deal undervalues companyAugust 31, 2023 | msn.comAbcam ADS Non-GAAP EPS of 16.8p, revenue of £203.2MAugust 30, 2023 | msn.comMedical tech firm Danaher to buy Abcam in $5.7 billion dealAugust 29, 2023 | msn.comDanaher buys Abcam, which has 250 employees in Waltham, for $5.7 billionAugust 29, 2023 | msn.comDanaher Wins Race to Acquire Abcam With $5.7 Billion DealAugust 29, 2023 | finance.yahoo.comDanaher (DHR) to Acquire Abcam, Boost Life Sciences UnitAugust 28, 2023 | msn.comAbcam acquired by Danaher Corp in deal valuing Cambridge life sciences company at $5.7bnAugust 28, 2023 | markets.businessinsider.comDanaher To Acquire Abcam In About $5.7 Bln All-cash DealAugust 28, 2023 | reuters.comMedical tech firm Danaher to buy Abcam in deal valued at $5.7 blnAugust 26, 2023 | seekingalpha.comAbcam: Further Upside Limited With Potential Acquisition In The Making, Reiterate HoldSee More Headlines Receive ABC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:ABC CUSIPN/A CIKN/A Webwww.abcam.com Phone+44-1223-696000FaxN/AEmployees1,650Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio20,433.33 Forward P/E Ratio33.28 P/E Growth1.57Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio31.60 Current Ratio1.27 Quick Ratio0.89 Sales & Book Value Annual Sales£350.40 million Price / Sales8.02 Cash FlowGBX 50.93 per share Price / Cash Flow24.07 Book ValueGBX 318.30 per share Price / Book3.85Miscellaneous Outstanding Shares229,272,000Free FloatN/AMarket Cap£2.81 billion OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Alan Thomas Hirzel BS (Age 54)M.B.A., M.S., MBA, MS, CEO & Exec. Director Comp: $1.23MMr. Michael Shaun Baldock B.A. (Age 58)CFO & Director Comp: $881.14kMr. Mark DermodyInterim CIOJames StaveleyVP of Investor RelationsMarc PerkinsGen. Counsel & Company Sec.Emma SceatsSr. VP of Sales, Service & Bus. Devel.Mr. Nick SkinnerSr. VP of HRMr. Mark BushfieldSr. VP of Research & InnovationMs. Kirstie Speck BBusScHead of Consumer InsightsMs. Yvonne ChienSr. VP of Customer ExperienceMore ExecutivesKey CompetitorsBTGLON:BTGOxford Nanopore TechnologiesLON:ONTGenusLON:GNSUDG HealthcareLON:UDGHUTCHMEDLON:HCMView All Competitors ABC Stock Analysis - Frequently Asked Questions How have ABC shares performed in 2023? Abcam's stock was trading at GBX 1,226 at the beginning of the year. Since then, ABC stock has increased by 0.0% and is now trading at GBX 1,226. View the best growth stocks for 2023 here. What other stocks do shareholders of Abcam own? Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), HSBC (HSBA), Royal Dutch Shell (RDSA) and Centrica (CNA). How do I buy shares of Abcam? Shares of ABC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:ABC) was last updated on 12/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abcam plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.